Miltenyi Biotec

Jan 10, 2025 | streetinsider.com | Miltenyi Biotec

1. TCS:IN2. IGMS3. NVDA4. TSLA5. APPF6. AJG7. AMD8. T9. DSCSY10. AVGO Tweet Share E-mail0 shares Get Alerts TECH Hot Sheet Join SI Premium – FREE , /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of new designer proteins engineered using advanced Artificial Intelligence (AI) based design platforms and protein evolutionary workflows.

Jan 8, 2025 | finanzen.at | Miltenyi Biotec

(RTTNews) - Bio-Techne Corp. (TECH), a life sciences company, announced Tuesday that it has won a second claim of reverse engineering by Miltenyi Biotec B.V. & Co. KG, which may appeal the Court's ruling. The company noted that Miltenyi commercialized antibodies developed based on information obtained by reverse engineering Bio-Techne's proprietary R&D Systems branded NKG2C/CD159c antibodies.

Jan 7, 2025 | nasdaq.com | Miltenyi Biotec

(RTTNews) - Bio-Techne Corp. (TECH), a life sciences company, announced Tuesday that it has won a second claim of reverse engineering by Miltenyi Biotec B.V. & Co. KG, which may appeal the Court's ruling. The company noted that Miltenyi commercialized antibodies developed based on information obtained by reverse engineering Bio-Techne's proprietary R&D Systems branded NKG2C/CD159c antibodies.

Jan 7, 2025 | streetinsider.com | Miltenyi Biotec

ArticleRelated Press Releases (1)Stock Quotes (1)1. NVDA2. NARI3. ULTA4. DNLI5. META6. SYK7. SSTK8. XPO9. GETY10. SLRN Tweet Share E-mail0 shares Get Alerts NCLH Hot Sheet Join SI Premium – FREE NCL Corporation Ltd. (“NCLC”), a subsidiary of Norwegian Cruise Line Holdings Ltd.

Jan 7, 2025 | finanzen.ch | Miltenyi Biotec

(RTTNews) - Bio-Techne Corp. (TECH), a life sciences company, announced Tuesday that it has won a second claim of reverse engineering by Miltenyi Biotec B.V. & Co. KG, which may appeal the Court's ruling. The company noted that Miltenyi commercialized antibodies developed based on information obtained by reverse engineering Bio-Techne's proprietary R&D Systems branded NKG2C/CD159c antibodies.